# Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

> **NCT02101853** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 669 (actual)

## Conditions studied

- Recurrent B Acute Lymphoblastic Leukemia

## Interventions

- **PROCEDURE:** Allogeneic Hematopoietic Stem Cell Transplantation
- **DRUG:** Asparaginase
- **BIOLOGICAL:** Blinatumomab
- **DRUG:** Cyclophosphamide
- **DRUG:** Cytarabine
- **DRUG:** Dexamethasone
- **DRUG:** Etoposide
- **DRUG:** Leucovorin Calcium
- **DRUG:** Mercaptopurine
- **DRUG:** Methotrexate
- **DRUG:** Mitoxantrone
- **DRUG:** Mitoxantrone Hydrochloride
- **DRUG:** Pegaspargase
- **OTHER:** Pharmacological Study
- **RADIATION:** Radiation Therapy
- **DRUG:** Therapeutic Hydrocortisone
- **DRUG:** Thioguanine
- **DRUG:** Vincristine
- **DRUG:** Vincristine Sulfate

## Key facts

- **NCT ID:** NCT02101853
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-12-17
- **Primary completion:** 2021-06-30
- **Final completion:** 2026-09-16
- **Target enrollment:** 669 (ACTUAL)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02101853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02101853, "Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02101853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*